semaglutide being taken off the market Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s A proposal seeks to remove

In its Declaratory Statement, FDA explained that it will abstain from taking action against compound pharmacies so long as they discontinue making and distributing compounded tirzepatide before February 18, 2025

It IS the hormone

Table 1 Summary of published reports on the presence of different T2Rs in enteroendocrine cells and gastrointestinal tissues in rodents and humans

Semaglutide does promote weight loss through appetite suppression, but diet still plays an important role in maximizing results

The engineering of the pen eliminates the entire category of errors that compounded semaglutide users face

The Precision Peptide Genetic Test reveals predispositions in GLP-1 receptor signaling (GLP1R rs6923761) and metabolic pathways (FTO rs9939609, MC4R rs17782313) that influence how your body responds to semaglutide